9-1-2021Cross-posted from NIAID newsroom No Safety Concerns Found in Imbokodo Sub-Saharan Africa StudyAn investigational HIV vaccine tested in the “Imbokodo” clinic…
4-28-2021Cross-posted from NIAID Funding NewsDiagnose. Treat. Prevent. Respond.Such are the four pillars of the Ending the HIV Epidemic (EHE) initiative that represent k…
10-18-2016Violence and Social Harm Were Associated with Low AdherenceMost women who used an experimental vaginal ring for HIV prevention report that the physical act of s…
7-18-2016NIH Clinical Trial Will Clarify Relationship between Ring Adherence, HIV Infection RiskA new exploratory analysis of data from the ASPIRE study has found that u…
5-18-2016Advances in HIV/AIDS research have given us the opportunity to transform the lives of those living with HIV while providing highly effective methods of preventi…
3-15-2016The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that it would move forward w…
2-22-2016A ring that continuously releases an experimental antiretroviral drug in the vagina safely provided a modest level of protection against HIV infection in women,…
7-28-2015Hepatitis C can be a chronic condition that leads to liver failure, and treatments often haven’t worked for patients who are also co-infected with HIV. Thanks…
6-12-2015In a new video, NIH researchers and their colleagues from health centers in the District of Columbia discuss efforts to improve treatments for hepatitis C, a po…
